Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Skin Elements Limited ( (AU:SKN) ) has shared an announcement.
Skin Elements Limited has secured $2.5 million through a two-tranche placement at $0.002 per share, with additional options, to fund the commercialization of its SE Formula biotechnology. This capital injection, managed by 62 Capital Pty Ltd, will support the company’s transition into commercial revenue programs, although it will result in a 64% dilution of current shareholders’ holdings.
More about Skin Elements Limited
Skin Elements Limited operates in the biotechnology industry, focusing on all-natural antimicrobial biotechnology. The company’s primary products include the SE Formula, Soleo Organics sunscreen, PapayaActivs therapeutic skincare, SuprCuvr disinfectant, and ECO-Nurture agriculture biostimulant, targeting personal protection and agricultural markets.
Current Market Cap: A$3.15M
For detailed information about SKN stock, go to TipRanks’ Stock Analysis page.